Bronchial Thermoplasty | UnityPoint Health - Cedar Rapids

St. Luke's Emergency Department

First Available Time :

Pediatric Urgent Care - Cedar Rapids

855 A Avenue NE
Suite 300A
Cedar Rapids, Iowa 52402

01 Patients
Waiting Now

Urgent Care - Anamosa

1795 Hwy 64 East
Anamosa, Iowa 52205

00 Patients
Waiting Now

Urgent Care - Hiawatha

1001 N. Center Point Road
Suite A
Hiawatha, Iowa 52233

00 Patients
Waiting Now

Urgent Care - Marion

2992 7th Ave.
Marion, Iowa 52302

01 Patients
Waiting Now

Urgent Care - Westside

2375 Edgewood Rd SW
Cedar Rapids, Iowa 52404

06 Patients
Waiting Now
UnityPoint Health - St. Luke's Hospital

Does asthma limit your activities?

St. Luke's Hospital now offers a new, non-medicated treatment for patients with severe asthma called Bronchial Thermoplasty (BT). BT is a minimally invasive, outpatient bronchoscopic procedure. 79 percent of patients treated with BT, saw a significant improvement in their asthma-related quality of life. 

The procedure is performed in three outpatient visits, each scheduled approximately three weeks apart. The first procedure treats the airways in the right lower lobe, the second treats the airways of the left lower lobe and the third and final procedure treats the airways in both upper lobes. After all three procedures, the treatment is complete. Moderate sedation is used and the procedure typically takes less than an hour. No incision is needed, because the procedure is performed using a bronchoscope.

To request a BT consult, please see the list of providers below or talk with your family doctor.

UnityPoint Clinic Multi-Specialty                  
855 A Ave. NE, Suite 400 | Cedar Rapids                                                  
Phone: (319) 363-3565                                          

Muhammad U. Anwer, MD                             
Hamad Azam, MD
Vijaya Gogineni, MD

Please note that individual BT treatment results may vary. BT is an add-on therapy that supplements your current asthma medications. BT, delivered by the Alair System, is indicated for the treatment of severe asthma in people 18 years and older whose asthma is not well controlled with inhaled corticosteroids and long-acting beta-agonists.